Product name | Recombinant Human IkB-alpha/NFKBIA Protein |
---|---|
Catalog No. | RP00032 |
Description | Recombinant Human IkB-alpha/NFKBIA Protein is produced by E. coli expression system. The target protein is expressed with sequence (Phe2-Leu317) of human IkB-alpha (Accession #NP_065390.1). |
Bio-Activity | Measured by its binding ability in a functional ELISA. Immobilized Human IkB-alpha Protein at 2 μg/mL (100 μL/well) can bind IκBα Rabbit mAb with a linear range of 0.195-0.64 ng/mL. |
Purity | > 90% by SDS-PAGE. |
Endotoxin | < 1.0 EU/μg of the protein by LAL method. |
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. |
Species | Human |
Calculated MW | 35.48 kDa |
Synonym | IKBA; MAD-3; NFKBI; NFKBIA; MAD-3; NFKBI; IKB alpha; EDAID2; IKBA; NFKB inhibitor alpha |
---|---|
Expression Host | E. coli |
Tag | No tag |
Swiss-Prot | |
Gene ID |
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
* For research use only. Not for therapeutic or diagnostic purposes.
Publishing research using RP00032? Please let us know so that we can cite the reference in this datasheet.